Global Influenza Market is Estimated to Reach $7 Billion by 2024, Says Accurize Market Research

Posted August 16, 2019 by jayashripatil

Global Influenza Market is expected to grow at CAGR of 3.4% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Influenza Market.

Global Influenza Market report published by Accurize Market Research forecast that the global market is expected to reach $7 billion by 2024; growing at a CAGR of 3.4% from 2017 to 2025. By geography, the Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period.

Request Sample:

Increasing study and development activities, technological improvements in recombinant DNA technology, and growing healthcare expenditure fuel the market

Increasing study and development activities, growing investment by companies for the improvement of influenza vaccine, technological improvements in recombinant DNA technology, the huge number of population with no immunization against influenza viruses in emerging markets, growing healthcare expenditure fuel the demand for the global influenza market. Furthermore, increasing healthcare expenditures, the aging population and increasing the occurrence of chronic diseases also boost the growth of the market.

Market Segmentation

The global influenza market has been bifurcated on the basis of vaccine, end-user, and geography. The vaccine segment is further segmented into trivalent and quadrivalent. The end-user segment includes children and adolescents, adults and the elderly. By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).

Request Customization:

Top players in the market

The key players operational in the market includes Alvogen, Abbott Laboratories, Chiron Corporation, Daiichi Sankyo Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Nanotherapeutics Inc., Roche Holding Ag, Shionogi & Co. Ltd., Sinovac Biotech Ltd., AstraZeneca, Biocryst Pharmaceuticals Inc., CSL Limited, Emergent Biosolutions, GlaxoSmithKline, Protein Sciences Corporation, Sanofi Pasteur Inc. and Serum Institute Of India Pvt. Ltd.among others.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By jpatil
Country India
Categories Electronics , Semiconductors
Tags forecast , industry , influenza market , regional , report , revenue , size , trend
Last Updated August 16, 2019